C

CTI Biopharma Corp
F:CEPS

Watchlist Manager
CTI Biopharma Corp
F:CEPS
Watchlist
Price: 28 EUR
Market Cap: 3.7B EUR

EV/OCF
Enterprise Value to OCF

-52.9
Current
-48.5
Median
5.7
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-52.9
=
Enterprise Value
3.7B EUR
/
Operating Cash Flow
-82.3m USD
 
US
C
CTI Biopharma Corp
F:CEPS
Average EV/OCF: 20.5
Negative Multiple: -52.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -211 765.6
US
Abbvie Inc
NYSE:ABBV
24.3
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -14 474
US
Amgen Inc
NASDAQ:AMGN
17.3
US
Gilead Sciences Inc
NASDAQ:GILD
15
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.6
AU
CSL Ltd
ASX:CSL
31.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -83.5

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A